Status:
COMPLETED
Intervention Study of Communication in Oncologist-Patient Encounters
Lead Sponsor:
Duke University
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Advanced Cancer
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The overall goal of this study is to improve communication between patients with advanced cancer and their oncologists. A web-based communication intervention will be delivered to patients to help the...
Detailed Description
Patients will be recruited from the practices of participating oncologists; therefore, physicians will be enrolled prior to their patients. All medical, surgical and radiation oncology faculty and hem...
Eligibility Criteria
Inclusion
- speak English;
- have a diagnosis of advanced cancer (Stage IV or however defined for that disease group), metastatic disease, or refractory or recurrent illness;
- have access to a telephone; and,
- have regular access to a computer with broadband Internet service and an email account.
Exclusion
- incompetent for interview (documented diagnosis of active psychosis or dementia) or unable to provide informed consent as assessed by the interviewer;
- hearing impaired or have a speech disorder;
- physically impaired in such a way that precludes the use of a computer;
- simply too sick to participate, and cannot realistically participate in the interview, as judged by the research assistant; or
- does not have another appointment with an enrolled oncologist within three months.
- has dial-up Internet service, or
- does not meet IES Score.
- While only patient subjects with advanced cancer will be eligible for randomization into one of the study arms, healthy volunteers (providers and third parties) will be enrolled in the study, too. Patients will be recruited from the practices of participating oncologists; therefore, physicians will be enrolled prior to their patients. All medical, surgical and radiation oncology faculty and hematology/oncology fellows who see patients in the participating clinics will be eligible for the study. We also will enroll the mid-level providers (i.e., physician assistants and nurse practitioners) who work with many of these oncologists and any third party (friends, family members) who comes to clinic with the enrolled patient.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2014
Estimated Enrollment :
659 Patients enrolled
Trial Details
Trial ID
NCT00994578
Start Date
November 1 2010
End Date
April 1 2014
Last Update
September 12 2014
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke University Health System
Durham, North Carolina, United States, 27705
2
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15213-2582